Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
02/2005
02/01/2005US6849739 N-heterocyclic derivatives as NOS inhibitors
02/01/2005US6849733 Compounds containing amidated guanidine derivative type functional group of structure N-C(=N)-N-CO-N-C=N or N-C(=N)-N-CO-N
02/01/2005US6849651 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
02/01/2005US6849647 Amide compounds and medications containing the same technical field
02/01/2005US6849639 Anticancer agents, antiinflamatory agents, osteoporosis, atherosclerosis
02/01/2005US6849636 Useful for treatment of noninsulin-dependent diabetes, hyperglycemia, obesity, insulin resistance, dyslipidemia, hyperlipidemia, hypertension, Metabolic Syndrome
02/01/2005US6849622 May be useful for the prophylaxis and treatment of diabetes, particularly type 2 diabetes, and for prophylaxis and treatment of other diseases induced or exacerbated by impaired glucose tolerance
02/01/2005US6849621 Treating: allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep
02/01/2005US6849367 Photoconductive layer containing azo compound; electrostaticlatent image
02/01/2005CA2183976C Process for making an epoxide
01/2005
01/27/2005WO2005014589A1 Benzoxazinone-derived sulfonamide compounds, their preparation and use as medicaments
01/27/2005WO2005007648A2 Biaryl piperazinyl-pyridine analogues
01/27/2005WO2005007647A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
01/27/2005WO2005007629A1 Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity
01/27/2005WO2005007628A1 Tetrahydroquinoline derivatives as cannabinoid receptor modulators
01/27/2005WO2005007625A2 Heterocyclic amides with anti-tuberculosis activity
01/27/2005WO2005007157A1 Pyrazolines as par-1 antagonists for treatment of cardiovascular diseases
01/27/2005WO2005007111A2 Tetrahydroquinoline derivatives as cannabinoid receptor modulators
01/27/2005WO2004101512A3 Naphthyridine integrase inhibitors
01/27/2005WO2004099197A3 Substituted oxyarenes, and use thereof for controlling pests
01/27/2005WO2004098518A3 Pyrazole-amide compounds useful as kinase inhibitors
01/27/2005WO2004096757A8 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
01/27/2005WO2004091613A3 Substituted phenyl acetamides and their use as protease inhibitors
01/27/2005WO2004087647A3 4-substituted quinolein derivatives with antimicrobial activity
01/27/2005US20050020849 via non-racemic cinchona-alkaloid-type catalyst (quinidine) for addition of nucleophile
01/27/2005US20050020837 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists
01/27/2005US20050020661 Antidiabetic agents
01/27/2005US20050020659 Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists
01/27/2005US20050020632 Optical isomers of an iloperidone metabolite
01/27/2005US20050020618 Antidiabetic agents; obesity
01/27/2005US20050020611 Phosphodiesterase inhibitor; antihistamines; antiallergens
01/27/2005US20050020602 Bone disorders; reduction concentration of parathyroid hormone in blood
01/27/2005US20050020597 Attention deficit disorders; hyperactivity; post-trauma stress disorders; anxiolytic agents; obsessive compulsive disorders; analgesics; Parkinson's disease
01/27/2005US20050020590 Antiinflammatory agents; autoimmune disease; bone disorders; viricides; antiproliferative agents; antiarthritic agents
01/27/2005US20050020578 Oxidoreductase enzyme inhibitors such as (R)-1-[4-(2-methyl-4-phenyl-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl)-pyrimidin-2-yl-ethanol, used as antidiabetic agents
01/27/2005US20050020571 Antiserotonine agents; psycholgical disorders; headaches
01/27/2005US20050020565 Pyrazole compound; gastrointestinal disorders; central nervous system disorders
01/27/2005US20050020451 2,6 Substituted pyridine-3-carbonyl derivatives serving as plant protection agents having herbicidal action
01/27/2005CA2534095A1 Benzoxazinone-derived sulfonamide compounds, their preparation and use as medicaments
01/27/2005CA2532316A1 Pyrazolines as par-1 antagonists for treatment of cardiovascular diseases
01/27/2005CA2532152A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
01/27/2005CA2531619A1 Biaryl piperazinyl-pyridine analogues
01/27/2005CA2529790A1 Heteroaryloxy nitrogenous saturated heterocyclic derivative
01/27/2005CA2528774A1 Small molecule toll-like receptor (tlr) antagonists
01/26/2005EP1500657A1 Substituted pyrazoles as P38 kinase inhibitors
01/26/2005EP1500654A1 Benzoxazinone derivatives, the preparation and use thereof as medicaments
01/26/2005EP1500652A1 Quinazoline derivative and medicine
01/26/2005EP1499612A1 Piperidine ouracil used as a medicament for treating bacterial infections
01/26/2005EP1499611A1 Process for 5- 2(r)- 1(r)- 3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1,2,4-triazol-3-one
01/26/2005EP1499609A2 Pesticidal heterocycles
01/26/2005EP1499600A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
01/26/2005EP1499316A1 (1-4-piperidinyl)benzimidazole derivatives useful as histamine h3 antagonists
01/26/2005EP1499313A2 Heterocyclic derivatives as opioid receptor modulators
01/26/2005EP1499311A1 Substituted benzazoles and use thereof as raf kinase inhibitors
01/26/2005EP1379522B1 DIHYDRO-BENZO(b)(1,4)DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS I
01/26/2005EP1185524B1 3-heteroarylalkyl substituted gaba analogs
01/26/2005EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds
01/26/2005EP0920423B1 Disubstituted morpholine, oxazepine or thiazepine derivatives, their preparation and their use as dopamine d4 receptor antagonists
01/26/2005EP0844877B1 Use of oxido-squalene cyclase inhibitors to lower blood cholesterol
01/26/2005CN1569853A Heterofluorene derivative with strong two photon absorption character
01/26/2005CN1186342C Substituted (4-bromopyrazole-3-yl) indole
01/26/2005CN1186339C Pyrimidinyl methyl indole derivatives with antibacterial activity
01/26/2005CN1186328C Substd. 5-benzyl-2, 4-diaminopyrimidines
01/26/2005CN1186326C Propane-1, 3-dione derivatives
01/26/2005CN1186322C Proline derivatives and use thereof as drugs
01/26/2005CN1186318C Novel benzenesulphonamide compound, its prepn. process and medicinal compsns. contg. them
01/25/2005US6846934 Photochromic diarylethene substituted with isoxazole group
01/25/2005US6846928 Compositions useful as inhibitors of protein kinases
01/25/2005US6846839 Identifying indolinone compounds that inhibit growth factor stimulated cell proliferation by contacting cells with compounds and with selected growth factors and monitoring inhibitory effect
01/25/2005US6846834 Antiinflammation agents
01/25/2005US6846829 N-heterocyclic derivatives as NOS inhibitors
01/25/2005US6846827 Antiinflammatory agents; antiallergens; antiarthritic agents
01/25/2005US6846824 E.g., ethyl 3-(4-(2-(3-oxo-2H-1,4-benzoxazin-4-yl)ethoxy)-phenyl-2-ethoxypropenoate where 1,4-benzothiazine or quinoxaline can be substituted for the benzoxazine ring; anticholesterol, diabetic agents; obesity; hyperlimpidemia
01/25/2005US6846820 For therapy of diabetes, hyperglycemia, hypercholesterolemia, hypertension, hyperinsulinemias, hyperlipidemia, atherosclerosis and myocardial ischemia in mammals
01/25/2005US6846814 Neurokinin antagonists for use as medicaments
01/25/2005CA2309352C Heterocyclic-substituted tricyclics as thrombin receptor antagonists
01/25/2005CA2129455C Orally active azole derivatives
01/25/2005CA2103383C Quinazoline derivatives
01/20/2005WO2005005438A1 Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting prot ein kinases
01/20/2005WO2005005428A1 Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics
01/20/2005WO2005005422A1 Oxazolidinone antibiotics and derivatives thereof
01/20/2005WO2005005421A1 Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds
01/20/2005WO2005005420A1 Cyclopropyl group substituted oyazolidinone antibiotics and derivatives thereof
01/20/2005WO2005005417A1 Pyrrole-2, 5-dione derivatives as liver x receptor modulators
01/20/2005WO2005005399A1 Oxazolidinone antibiotics and derivatives thereof
01/20/2005WO2005005398A2 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
01/20/2005WO2005005395A2 Arylamine-substituted quinazolinone compounds
01/20/2005WO2005005392A1 Azacyclic compounds as inhibitors of sensory neurone specific channels
01/20/2005WO2005005389A2 Malonamide derivatives
01/20/2005WO2005005380A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
01/20/2005WO2005004866A1 Therapeutic agents useful for treating pain
01/20/2005WO2005004810A2 Arylsulfonamide derivatives
01/20/2005WO2005004801A2 Indole, azaindole and related heterocyclic n-substituted piperazine derivatives
01/20/2005WO2004096129A3 Inhibitors of akt activity
01/20/2005WO2004092166A3 Cgrp receptor antagonists
01/20/2005WO2004074218A3 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
01/20/2005WO2004069158A3 Substituted pyrazoles, compositions containing such compounds and methods of use
01/20/2005US20050014942 Transforming growth factor inhibitor; controllign cell differentiation, cell proliferation
01/20/2005US20050014938 Phenyl substituted triazoles and their use as selective inhibitors of akl5 kinase
01/20/2005US20050014833 Cyclic compound and ppar agonist